Aim:Castor is a novel single-branched stent graft system for endovascular repair of aortic arch dissection. This is a prospective, one-arm, open, multi-center, pre-market study of Castor stent to evaluate its efficacy and safety in treatment of aortic dissection. Number of patients: 70 patients will be included and undertaken endovascular repair with Castor stent. Follow-up: 1.aortic computed tomographic angiography (CTA) examination 6 and 12 months after the surgery 2.telephone or clinical follow-up 30 days and 2-5 years after the surgery Primary Outcome Measure: success rate of endovascular repair for efficacy measurement. Secondary Outcome Measure: 1 year stent related adverse event rate for safety measurement. Other Outcome Measures: 1. efficacy: * 1 year success rate of treatment * 1 year patency rate of branch stent 2. safety: * in-hospital mortality * complication rate of neural system * 1 year dissection or stent related mortality
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
70
Endovascular Repair of Aortic Dissection
Department of Vascular Surgery, Changhai Hospital
Shanghai, Shanghai Municipality, China
RECRUITINGsuccess rate of endovascular repair
\- during the surgery: successful conduction, accurate positioning and release, and no warping, folding, narrowing or blocking of the stent graft system. Immediately after the stent release, angiography shows both main stent and side arm stent patency, successful exclusion of dissection and no arteriorrhexis or dissection rupture.
Time frame: during the surgery
1 year stent related adverse event rate
* unexpected breakage and shifting of the stent * type I or type III endoleak which needs intervention * dissection rupture around the stent
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.